Enzon Pharmaceuticals Inc
(ENZN)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-1992 | 12-1991 | 12-1990 | 12-1989 | 12-1988 | |
| Sales | 2,200 | 795 | 795 | 0 | 944 |
| Cost of Goods | 262 | 375 | 375 | 0 | 598 |
| Gross Profit | 1,938 | 420 | 420 | 0 | 346 |
| Operating Expenses | 8,496 | 4,132 | 4,132 | 2,852 | 2,787 |
| Operating Income | -6,296 | -3,337 | -3,337 | -2,852 | -1,843 |
| Interest Expense | 14 | 2 | 2 | 30 | 6 |
| Other Income | 112 | 401 | 401 | 181 | 145 |
| Pre-tax Income | -6,199 | -2,938 | -2,938 | -2,700 | -1,704 |
| Net Income Continuous | -28,183 | -11,961 | -8,039 | 948 | -1,704 |
| Net Income | $-6,199 | $-2,938 | $-2,938 | $-2,700 | $-1,704 |
| EPS Basic Total Ops | -0.29 | -0.16 | -0.23 | -0.22 | -0.16 |
| EPS Basic Continuous Ops | -1.39 | -0.60 | -0.58 | 0.08 | -0.15 |
| EPS Diluted Total Ops | -0.31 | -0.15 | -0.21 | -0.22 | -0.15 |
| EPS Diluted Continuous Ops | -1.39 | -0.60 | -0.58 | 0.08 | -0.15 |
| EBITDA(a) | $-6,296 | $-3,337 | $-3,337 | $-2,852 | $-1,843 |